[New options for the pharmacotherapy of Alzheimer's disease after the registration of memantine?]

Dtsch Med Wochenschr. 2005 Feb 25;130(8):408-12. doi: 10.1055/s-2005-863066.
[Article in German]
No abstract available

Publication types

  • Review

MeSH terms

  • Alzheimer Disease / drug therapy*
  • Cholinesterase Inhibitors / therapeutic use*
  • Dopamine Agents / therapeutic use*
  • Drug Therapy, Combination
  • Humans
  • Memantine / therapeutic use*
  • Neuroprotective Agents / therapeutic use
  • Nootropic Agents / therapeutic use*
  • Receptors, N-Methyl-D-Aspartate / antagonists & inhibitors
  • Receptors, N-Methyl-D-Aspartate / drug effects
  • Severity of Illness Index
  • Treatment Outcome

Substances

  • Cholinesterase Inhibitors
  • Dopamine Agents
  • Neuroprotective Agents
  • Nootropic Agents
  • Receptors, N-Methyl-D-Aspartate
  • Memantine